Sanofi (LON:0O59)

Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of GBP 91.43 billion. The enterprise value is 102.97 billion.

Market Cap	91.43B
Enterprise Value	102.97B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	May 12, 2025

Share Statistics

Current Share Class	1.22B
Shares Outstanding	n/a
Shares Change (YoY)	-1.65%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	58.24%
Float	1.10B

Valuation Ratios

The trailing PE ratio is 11.49 and the forward PE ratio is 10.41.

PE Ratio	11.49
Forward PE	10.41
PS Ratio	2.28
PB Ratio	1.42
P/TBV Ratio	23.83
P/FCF Ratio	11.16
P/OCF Ratio	9.42
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.19, with an EV/FCF ratio of 12.57.

EV / Earnings	12.95
EV / Sales	2.55
EV / EBITDA	9.19
EV / EBIT	12.08
EV / FCF	12.57

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.30.

Current Ratio	1.06
Quick Ratio	0.29
Debt / Equity	0.30
Debt / EBITDA	1.72
Debt / FCF	2.32
Interest Coverage	24.55

Financial Efficiency

Return on equity (ROE) is 8.84% and return on invested capital (ROIC) is 6.25%.

Return on Equity (ROE)	8.84%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.25%
Return on Capital Employed (ROCE)	9.83%
Revenue Per Employee	483,740
Profits Per Employee	95,977
Employee Count	82,878
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Sanofi has paid 1.34 billion in taxes.

Income Tax	1.34B
Effective Tax Rate	19.14%

Stock Price Statistics

The stock price has decreased by -11.32% in the last 52 weeks. The beta is 0.37, so Sanofi's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-11.32%
50-Day Moving Average	83.42
200-Day Moving Average	90.36
Relative Strength Index (RSI)	49.28
Average Volume (20 Days)	959,473

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of GBP 40.09 billion and earned 7.95 billion in profits. Earnings per share was 6.45.

Revenue	40.09B
Gross Profit	28.87B
Operating Income	8.38B
Pretax Income	6.99B
Net Income	7.95B
EBITDA	10.77B
EBIT	8.38B
Earnings Per Share (EPS)	6.45

Balance Sheet

The company has 7.77 billion in cash and 18.99 billion in debt, giving a net cash position of -11.22 billion.

Cash & Cash Equivalents	7.77B
Total Debt	18.99B
Net Cash	-11.22B
Net Cash Per Share	n/a
Equity (Book Value)	64.18B
Book Value Per Share	52.50
Working Capital	1.69B

Cash Flow

In the last 12 months, operating cash flow was 9.70 billion and capital expenditures -1.51 billion, giving a free cash flow of 8.19 billion.

Operating Cash Flow	9.70B
Capital Expenditures	-1.51B
Free Cash Flow	8.19B
FCF Per Share	n/a

Margins

Gross margin is 72.00%, with operating and profit margins of 20.90% and 19.84%.

Gross Margin	72.00%
Operating Margin	20.90%
Pretax Margin	17.43%
Profit Margin	19.84%
EBITDA Margin	26.85%
EBIT Margin	20.90%
FCF Margin	20.43%

Dividends & Yields

This stock pays an annual dividend of 3.30, which amounts to a dividend yield of 3.87%.

Dividend Per Share	3.30
Dividend Yield	3.87%
Dividend Growth (YoY)	2.06%
Years of Dividend Growth	1
Payout Ratio	51.62%
Buyback Yield	1.65%
Shareholder Yield	5.52%
Earnings Yield	8.70%
FCF Yield	8.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4